← Evidence map

ArticleMolecular oncology2019

SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity.

Huiquan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31199048